The Sentinel


Thursday, July 27, 2017

President's Message - July 2017

Dear Colleagues,

One of the pillars of the Society for Immunotherapy of Cancer’s (SITC) Strategic Plan is to “advance the science globally.” For more than 31 years, SITC has collaborated with international partners to further the field and application of cancer immunotherapy worldwide.

See what SITC has been up to around the globe:

SITC Members and International Advisory Committee
SITC recently formed the International Advisory Committee charged with building relationships with international cancer immunotherapy organizations, with the aim of providing collaborative international SITC educational activities to further stimulate immunotherapy research and global membership.

International Educational Collaborations
Already in 2017, SITC has reached more than 1,900 people internationally through collaborative educational programs. SITC continues to play an important role as the educational partner in the Immunotherapy of Cancer Conference (ITOC) series, which was presented by the Cancer Drug Development Forum (CDDF).

World Immunotherapy Council
SITC and the World Immunotherapy Council (WIC) will host the 2nd World Immunotherapy Council Young Investigator Symposium during SITC’s 32nd Annual Meeting & Pre-Conference Programs on Nov. 8, 2017. The program will provide the opportunity for young scientists and future leaders throughout the world to engage in scientific exchange to facilitate development and global dissemination of cancer immunotherapies. Learn more.

SITC Cancer Immunotherapy CONNECT and SITC Cancer Immunotherapy connectED
SITC bridges geographical distances through technology and develops targeted education to advance cancer immunotherapy. Through SITC CONNECT and SITC connectED, users around the world access the latest news, research and conversation through a community platform centered on cancer immunotherapy.

SITC Collaborations and Partnerships
Collaboration has been integral to SITC’s success as the source and resource for all things related to cancer immunotherapy. SITC works with global partners to further the field worldwide. Learn more.
Journal of ImmunoTherapy of Cancer

The Journal of ImmunoTherapy of Cancer (JITC) is an exceptional international journal exemplified by its 40 international editors and high global readership. Nearly half of the monthly visitors to JITC are from outside the U.S. Learn more.

SITC will continue to work with and address the concerns of our international members and collaborators around the globe to drive the field of cancer immunotherapy into the future. Thank you for your continued support.

Best wishes,

Lisa H. Butterfield, PhD

SITC President

No comments:

Post a Comment